Why Fed. Circ. Should Explain Treatment Of Prior Art Ranges
The U.S. Court of Appeals for the Federal Circuit recently issued a decision in UCB Inc. v. Actavis Laboratories UT Inc. regarding the patentability of claimed ranges where the prior art discloses overlapping...To view the full article, register now.
Already a subscriber? Click here to view full article